Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  BioMérieux       FR0010096479

BIOMÉRIEUX
Mes dernières consult.
Most popular
Report
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

BIOMERIEUX : Detection of Schmallenberg virus made possible by bioMérieux: the ADIAGENE PCR kit has been validated by ANSES

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/28/2012 | 06:50pm CET

Detection of Schmallenberg virus made possible by bioMérieux: the ADIAGENE PCR kit has been validated by ANSES

Marcy l'Etoile, France - March 27, 2012. ADIAGENE, a member of the bioMérieux group and specialized in diagnostics for animal health, has obtained ANSES validation for a kit for the detection of Schmallenberg virus, responsible for the epidemic currently affecting livestock in Europe. Based on molecular biology techniques, the new ADIAVET™ Schmallenberg virus PCR detection kit was developed by ADIAGENE in close collaboration with the French Agency for Food, Environmental and Occupational Health and Safety (ANSES, Maisons-Alfort, France). The Direction Générale de l'Alimentation (DGAL) has just authorized its use in certified French public veterinary laboratories.

distributed by

This press release was issued by BioMérieux SA and was initially posted at http://www.biomerieux.com/servlet/srt/bio/portail/dynPage?open=PRT_NWS_REL&doc=PRT_NWS_REL_G_PRS_RLS _269 . It was distributed, unedited and unaltered, by noodls on 2012-03-28 18:43:26 PM. The issuer is solely responsible for the accuracy of the information contained therein.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BIOMÉRIEUX
01/15 BIOMERIEUX : CNES and bioMérieux extend their collaboration on Aquapad, a unique..
01/11 BIOMERIEUX : Federal Contracts Awarded by Federal Agencies in South Dakota (Jan...
01/10 BIOMERIEUX : Reagent - AST-ST02 TEST KIT (Biomerieux)
01/10 BIOMERIEUX : 66-- Reagent - AST-ST02 TEST KIT (Biomerieux)
2017 BIOCENTURY - MANAGEMENT TRACKS : Chugai, bioMerieux
2017 BIOMERIEUX : Alexandre Mérieux appointed Chairman and CEO of bioMérieux
2017 BIOMERIEUX : DIAGNOSTIC REAGENTS (TESTS AND SIGNATURE) BIOMERIEUX (or equivalent..
2017BIOMERIEUX SA : quaterly sales release
2017 BIOMERIEUX : $7,068 Federal Contract Awarded to BioMerieux
2017 BIOMERIEUX : SPLIT: 3 for 1
More news
News from SeekingAlpha
2017 Biomerieux 69 Marcy L'Etoile reports 1H results
2016 Biomerieux 69 Marcy L'Etoile reports 1H results
2016 Biomerieux 69 Marcy L'Etoile reports Q2 results
2016 Spin-out from bioMerieux secures $32M capital raise
2015 BioMerieux Q2 sales up 18%; sees 2015 top-line growth of 4.5 - 6.5%
Financials (€)
Sales 2017 2 307 M
EBIT 2017 332 M
Net income 2017 209 M
Debt 2017 214 M
Yield 2017 0,48%
P/E ratio 2017 43,98
P/E ratio 2018 37,88
EV / Sales 2017 4,14x
EV / Sales 2018 3,79x
Capitalization 9 339 M
Chart BIOMÉRIEUX
Duration : Period :
bioMérieux Technical Analysis Chart | FR0010096479 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 13
Average target price 67,2 €
Spread / Average Target -15%
EPS Revisions
Managers
NameTitle
Alexandre Mérieux Chairman & Chief Executive Officer
Claire Giraut Chief Financial Officer & Vice President
Mark Miller Chief Medical Officer
Alain Mérieux Director
Jean-Luc Bélingard Director
Sector and Competitors
1st jan.Capitalization (M$)
BIOMÉRIEUX48.06%11 463
BIOMERIEUX6.17%11 463
DIASORIN SPA7.70%5 470
AUTOBIO DIAGNOSTICS CO LTD-6.05%3 165
MACCURA BIOTECHNOLOGY CO LTD--.--%1 840
SIEGFRIED HOLDING AG0.62%1 420